111In-labelled polymeric nanoparticles incorporating a ruthenium-based radiosensitizer for EGFR-targeted combination therapy in oesophageal cancer cells

111In-labelled polymeric nanoparticles incorporating a ruthenium-based radiosensitizer for EGFR-targeted combination therapy in oesophageal cancer cells

Radiolabelled, drug-loaded nanoparticles may combine the theranostic properties of radionuclides, the controlled release of chemotherapy and cancer cell targeting. Here, we report the preparation of poly(lactic-co-glycolic acid) (PLGA) nanoparticles surface conjugated to DTPA-hEGF (DTPA = diethylene...

Full description

Bibliographic Details
Main Authors:	Gill, M, Menon, J, Jarman, P, Owen, J, Skaripa-Koukelli, I, Able, S, Thomas, J, Carlisle, R, Vallis, K
Format:	Journal article
Published:	Royal Society of Chemistry 2018

Similar Items

Indium-111 labelling of liposomal HEGF for radionuclide delivery via ultrasound-induced cavitation
by: Owen, J, et al.
Published: (2019)

Oligonucleotide-functionalized gold nanoparticles for synchronous telomerase inhibition, radiosensitization, and delivery of theranostic radionuclides
by: Bavelaar, BM, et al.
Published: (2021)

A three-in-one-bullet for oesophageal cancer: replication fork collapse, spindle attachment failure and enhanced radiosensitivity generated by a ruthenium(II) metallo-intercalator
by: Gill, MR, et al.
Published: (2017)

Ultrasound-mediated cavitation enhances the delivery of an EGFR-targeting liposomal formulation designed for chemo-radionuclide therapy
by: Thomas, E, et al.
Published: (2019)

Accumulation of 111In-Labelled EGF-Au-PEG Nanoparticles in EGFR-Positive Tumours is Enhanced by Co-administration of Targeting Ligand
by: Song, L, et al.
Published: (2017)

An 111In-labelled bis-ruthenium(ii) dipyridophenazine theranostic complex: mismatch DNA binding and selective radiotoxicity towards MMR-deficient cancer cells
by: Gill, MR, et al.
Published: (2020)

3-Bromopyruvate-mediated MCT1-dependent metabolic perturbation sensitizes triple negative breast cancer cells to ionizing radiation
by: Skaripa-Koukelli, I, et al.
Published: (2021)

Towards the synthesis and delivery of a halogenated MCT1 substrate
by: Skaripa-Koukelli, Eirini
Published: (2019)

3-Bromopyruvate-mediated MCT1-dependent metabolic perturbation sensitizes triple negative breast cancer cells to ionizing radiation
by: Irini Skaripa-Koukelli, et al.
Published: (2021-10-01)

In-111-labeled EGF is selectively radiotoxic to human breast cancer cells overexpressing EGFR
by: Reilly, R, et al.
Published: (2000)

111In-labeled EGF is selectively radiotoxic to human breast cancer cells overexpressing EGFR.
by: Reilly, R, et al.
Published: (2000)

A ruthenium polypyridyl intercalator stalls DNA replication forks, radiosensitizes human cancer cells and is enhanced by Chk1 inhibition
by: Gill, M, et al.
Published: (2016)

Transition metal compounds as cancer radiosensitizers
by: Gill, M, et al.
Published: (2018)

A ruthenium polypyridyl intercalator stalls DNA replication forks, radiosensitizes human cancer cells and is enhanced by Chk1 inhibition
by: Gill, Martin R., et al.
Published: (2016)

Radiosensitivity of colorectal cancer to 90Y and the radiobiological implications for radioembolisation therapy
by: Lee, B, et al.
Published: (2019)

Amplified delivery of indium-111 to EGFR-positive human breast cancer cells.
by: Wang, J, et al.
Published: (2001)

Molecular radiotherapy using cleavable radioimmunoconjugates that target eGFR and γH2AX
by: Cornelissen, B, et al.
Published: (2013)

SPECT imaging and biodistribution studies of 111In-EGF-Au-PEG nanoparticles in vivo
by: Song, L, et al.
Published: (2016)

Molecular radiotherapy using cleavable radioimmunoconjugates that target EGFR and γH2AX.
by: Cornelissen, B, et al.
Published: (2013)

Trastuzumab-resistant breast cancer cells remain sensitive to the auger electron-emitting radiotherapeutic agent 111In-NLS-trastuzumab and are radiosensitized by methotrexate.
by: Costantini, D, et al.
Published: (2008)

Methotrexate, paclitaxel, and doxorubicin radiosensitize HER2-amplified human breast cancer cells to the Auger electron-emitting radiotherapeutic agent (111)In-NLS-trastuzumab.
by: Costantini, D, et al.
Published: (2010)

Radiosensitization of non-small cell lung carcinoma by EGFR inhibition
by: Keta Otilija D., et al.
Published: (2014-01-01)

Megavoltage radiosensitization of gold nanoparticles on a Glioblastoma Cancer Cell Line using a clinical platform
by: Kazmi, F, et al.
Published: (2020)

Comparative antiproliferative effects of (111)In-DTPA-hEGF, chemotherapeutic agents and gamma-radiation on EGFR-positive breast cancer cells.
by: Chen, P, et al.
Published: (2002)

Megavoltage Radiosensitization of Gold Nanoparticles on a Glioblastoma Cancer Cell Line Using a Clinical Platform
by: Farasat Kazmi, et al.
Published: (2020-01-01)

Monitoring response to anti-angiogenic mTOR inhibitor therapy in vivo using (111)In-bevacizumab.
by: Patel, N, et al.
Published: (2017)

Human EGFR-2, EGFR and HDAC triple-inhibitor CUDC-101 enhances radiosensitivity of GBM cells
by: Cody D Schlaff, et al.
Published: (2015-01-01)

A phase I trial of In-111-human epidermal growth factor in patients with metastatic EGFR-positive breast cancer
by: Vallis, K, et al.
Published: (2008)

Auger electron therapy using In-111-labelled F3 peptide
by: Cornelissen, B, et al.
Published: (2011)

A comparison of EGF and MAb 528 labeled with 111In for imaging human breast cancer.
by: Reilly, R, et al.
Published: (2000)

Effect of the EGFR density of breast cancer cells on nuclear importation, in vitro cytotoxicity, and tumor and normal-tissue uptake of [111In]DTPA-hEGF.
by: Hu, M, et al.
Published: (2007)

Lamellipodin-RICTOR Signaling Mediates Glioblastoma Cell Invasion and Radiosensitivity Downstream of EGFR
by: Stefanie Moritz, et al.
Published: (2021-10-01)

EGFR-dependent Impact of Indol-3-Carbinol on Radiosensitivity  of Lung Cancer Cells
by: Xiao XIAO, et al.
Published: (2012-07-01)

Monitoring response to anti-angiogenic mTOR inhibitor therapy in vivo using 111In-bevacizumab
by: Neel Patel, et al.
Published: (2017-05-01)

Investigation of CO and OH adsorption and oxidation in the presence of cocatalytic ruthenium ions on the Pt(111) surface
by: Hung-Lung Chou, et al.
Published: (2022-02-01)

Targeted Delivery of 111In Into the Nuclei of EGFR Overexpressing Cells via Modular Nanotransporters With Anti-EGFR Affibody
by: Tatiana S. Karyagina, et al.
Published: (2020-03-01)

EGFR inhibitor C225 increases the radiosensitivity of human lung squamous cancer cells
by: Yang Ruijie, et al.
Published: (2010-10-01)

Blockade of Radiation-induced EGFR Nuclear Transport Enhances Radiosensitivity of Human Cervical Cancer
by: LI Lu, et al.
Published: (2020-01-01)

The Ibr-7 derivative of ibrutinib radiosensitizes pancreatic cancer cells by downregulating p-EGFR
by: Biqin Tan, et al.
Published: (2020-09-01)

Synthesis and evaluation of an 18F-labeled derivative of F3 for targeting surface expressed nucleolin in cancer and tumor endothelial cells
by: Vallis, K, et al.
Published: (2016)